91063-19-3

Basic information

• Product Name: 3-CHLORO-6-BENZYLOXYPYRIDAZINE
• Synonyms: 3-CHLORO-6-BENZYLOXYPYRIDAZINE
• CAS NO: 91063-19-3
• Molecular Formula: C₁₁H₉ClN₂O
• Molecular Weight: 220.65496
• Mol File: 91063-19-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3-CHLORO-6-BENZYLOXYPYRIDAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-6-BENZYLOXYPYRIDAZINE(91063-19-3)
• EPA Substance Registry System: 3-CHLORO-6-BENZYLOXYPYRIDAZINE(91063-19-3)

Safety Data

• Hazardous Substances Data: 91063-19-3(Hazardous Substances Data)

Usage

General Description

3-Chloro-6-benzyloxypyridazine is an organic compound with the chemical formula C12H9ClN2O. It belongs to the pyridazine family of compounds and features a chlorine atom at the 3-position and a benzyloxy group at the 6-position on the pyridazine ring. 3-CHLORO-6-BENZYLOXYPYRIDAZINE is used in the synthesis of pharmaceuticals and agrochemicals due to its potential for creating heterocyclic compounds with diverse biological activities. It is also used as a building block in organic synthesis for the production of various compounds with medicinal and agricultural applications. Due to its structural features and potential uses, 3-chloro-6-benzyloxypyridazine is the subject of ongoing research and development in the fields of chemistry, pharmaceuticals, and agrochemicals.

Upstream product

• 141-30-0 3,6-dichlorpyridazine 
• 20194-18-7 sodium phenyl-methanolate 
• 100-51-6 benzyl alcohol 

Downstream Products

• 3605-12-7 3-benzyloxy-1,6H-pyridazin-6-one 
• 454182-03-7 3-benzyloxy-6-mercapto-pyridazine 

Relevant articles and documents

2-HETEROARYL-PYRROLO [3,4-C]PYRROLE DERIVATIVES, AND USE THEREOF AS SCD INHIBITORS

The invention relates to compounds of the formula (I), where the groups R1, M, A, B, D, L, and R have the specified meanings, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for treating metabolic syndrome, in

Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors

This invention relates to novel sulfonyl pyridazinone compounds useful as aldose reductase inhibitors in the treatment or prevention of certain complications arising from diabetes mellitus, pharmaceutical compositions comprising the sulfonyl pyridazinone, pharmaceutical compositions comprising a combination of the sulfonyl pyridazinone together with a second pharmaceutical agent, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds in combination with a second pharmaceutical agent and compounds useful as intermediates for preparing the sulfonyl pyridazinone compounds of this invention.

Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors

Compounds of the formula (I): a prodrug thereof or a pharmaceutically acceptable salt of said compound or said prodrug, wherein R1, R2, X and Y are as defined in the claims are aldose reductase inhibitors useful in the treatment or p